Zhejiang DiAn Diagnostics Co (300244) - Total Liabilities
Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has total liabilities worth CN¥6.09 Billion CNY (≈ $891.28 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300244 cash flow metrics to assess how effectively this company generates cash.
Zhejiang DiAn Diagnostics Co - Total Liabilities Trend (2008–2024)
This chart illustrates how Zhejiang DiAn Diagnostics Co's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Zhejiang DiAn Diagnostics Co to evaluate the company's liquid asset resilience ratio.
Zhejiang DiAn Diagnostics Co Competitors by Total Liabilities
The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645
|
China | CN¥1.56 Billion |
|
Veris Residential Inc
NYSE:VRE
|
USA | $1.51 Billion |
|
Xinjiang Joinworld Co Ltd
SHG:600888
|
China | CN¥7.50 Billion |
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
USA | $27.39 Million |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
USA | $14.33 Billion |
|
Avi Ltd
JSE:AVI
|
South Africa | ZAC5.15 Billion |
|
Hyundai Doosan Infracore Co Ltd
KO:042670
|
Korea | ₩2.53 Trillion |
|
Indo Tambangraya Megah Tbk
JK:ITMG
|
Indonesia | Rp475.20 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Zhejiang DiAn Diagnostics Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang DiAn Diagnostics Co (300244) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang DiAn Diagnostics Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang DiAn Diagnostics Co (2008–2024)
The table below shows the annual total liabilities of Zhejiang DiAn Diagnostics Co from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
-12.64% |
| 2023-12-31 | CN¥8.03 Billion ≈ $1.18 Billion |
-30.46% |
| 2022-12-31 | CN¥11.55 Billion ≈ $1.69 Billion |
+42.32% |
| 2021-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+27.44% |
| 2020-12-31 | CN¥6.37 Billion ≈ $932.13 Million |
+13.51% |
| 2019-12-31 | CN¥5.61 Billion ≈ $821.19 Million |
-5.88% |
| 2018-12-31 | CN¥5.96 Billion ≈ $872.50 Million |
+34.20% |
| 2017-12-31 | CN¥4.44 Billion ≈ $650.13 Million |
+40.08% |
| 2016-12-31 | CN¥3.17 Billion ≈ $464.10 Million |
+157.15% |
| 2015-12-31 | CN¥1.23 Billion ≈ $180.48 Million |
+203.14% |
| 2014-12-31 | CN¥406.86 Million ≈ $59.54 Million |
+83.54% |
| 2013-12-31 | CN¥221.68 Million ≈ $32.44 Million |
+23.96% |
| 2012-12-31 | CN¥178.83 Million ≈ $26.17 Million |
+44.61% |
| 2011-12-31 | CN¥123.66 Million ≈ $18.09 Million |
+66.35% |
| 2010-12-31 | CN¥74.33 Million ≈ $10.88 Million |
+8.73% |
| 2009-12-31 | CN¥68.37 Million ≈ $10.00 Million |
-17.59% |
| 2008-12-31 | CN¥82.96 Million ≈ $12.14 Million |
-- |
About Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more